[Glioblastoma of the cerebellum in a child. Apropos of a case. A review of the literature].

Neurochirurgie

Service de Neurochirurgie, C.H.U. Jean Minjoz, Besançon.

Published: June 1989

Authors present a case of glioblastoma of cerebellum in a 11-year old child. Symptoms and signs are those of other tumors of posterior fossa. Diagnosis was made by CT Scan and pathologist. In spite of radiotherapy, he died one year after craniotomy. Only twenty cases of glioblastoma of cerebellum in childhood were described in the literature.

Download full-text PDF

Source

Publication Analysis

Top Keywords

glioblastoma cerebellum
8
[glioblastoma cerebellum
4
cerebellum child
4
child apropos
4
apropos case
4
case review
4
review literature]
4
literature] authors
4
authors case
4
case glioblastoma
4

Similar Publications

Modern insights of nanotheranostics in the glioblastoma: An updated review.

Biochim Biophys Acta Mol Basis Dis

January 2025

Department of Chemical and Biological Engineering, Gachon University, 1342 Seongnam Daero, Seongnam-Si, Gyeonggi-Do 13120, Republic of Korea. Electronic address:

Glioblastoma multiforme (GBM) is a highly malignant subtype of glioma, originating from the glial cells that provide support to other neurons in the brain. GBM predominantly impacts the cerebral hemisphere of the brain, with minimal effects on the cerebellum, brain stem, or spinal cord. Individuals diagnosed with GBM commonly encounter a range of symptoms, starting from auditory abnormalities to seizures.

View Article and Find Full Text PDF

Predicting Protein Pathways Associated to Tumor Heterogeneity by Correlating Spatial Lipidomics and Proteomics: The Dry Proteomic Concept.

Mol Cell Proteomics

December 2024

Univ.Lille, Inserm, CHU Lille, U1192 - Proteomics Inflammatory Response Mass Spectrometry- PRISM, Lille, France; Department Institut Universitaire de France, Ministère de l'Enseignement supérieur, de la Recherche et de l'Innovation, Paris, France. Electronic address:

Article Synopsis
  • Researchers introduced "dry proteomics," a method that uses MALDI MSI to study the relationship between lipids and proteins in tissues, focusing on spatial localization.
  • This approach was tested on rat brain tissue and later applied to human glioblastoma, revealing unique lipid signatures that correlate with specific proteins and biological pathways.
  • Despite challenges with incomplete lipid data from glioblastoma patients, a classification model based on protein information was developed to enhance prognostic predictions and understand tumor heterogeneity.
View Article and Find Full Text PDF

Total resection of glioblastoma (GB) tumors is nearly impossible, and systemic administration of temozolomide (TMZ) is often inadequate. This study presents a hybrid layered composite nanofiber mesh (LHN) designed for localized treatment in GB tumor bed. The LHN, consisting of polyvinyl alcohol and core-shell polylactic acid layers, was loaded with TMZ and rutin.

View Article and Find Full Text PDF

Not all patients with glioblastoma multiforme (GBM) eligible for systemic chemotherapy after upfront surgery and radiotherapy finally receive it. The information on patients with GBM was retrieved from the surveillance, epidemiology, and end results database. Patients who underwent upfront surgery or biopsy and external beam radiotherapy between 2010 and 2019 were eligible for systemic chemotherapy.

View Article and Find Full Text PDF

Glioblastoma is a primary malignant brain tumor; it is aggressive with a high degree of malignancy and unfavorable prognosis and is the most common type of malignant brain tumor. Glioblastomas can be located in the brain, cerebellum, brainstem, and spinal cord, originating from glial cells, particularly astrocytes. The databases MEDLINE, Scopus, Web of Science, Google Scholar, and CINAHL were researched up to January 2024.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!